NCT06750016

Brief Summary

The aim of this viability study is to investigate using a novel medical device, the potential for detecting partial blockages in the arteries within the wall of the heart (coronary artery stenosis). A prototype device will be used in the proposed study. It is a stick-on patch containing sensors which measure the vibration produced at the chest surface by flowing blood as it accelerates through the narrowed artery in the heart emerging downstream, hitting the inner wall of the artery and causing it to vibrate. Some of the energy in the vibrations reaches the skin of the chest, allowing the blockage to be detected non-invasively. The principle has been proved in the laboratory using a simple chest model but to date no measurements have been made in people. Therefore, the proposed trial will serve as the first in-human measurements and will involve a small number of patients and healthy volunteers, with the objective of establishing if it is possible to determine the presence or absence of the stenosis. The patch will be tested by recording acoustic signatures in healthy volunteers, then in patients undergoing coronary CT angiography. Results will be validated against the CT angiography gold standard. At this early stage no clinical decisions will be made based on the patch recordings and the data will be used only to assess the feasibility of continuing the development of the device.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 27, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

5 months

First QC Date

December 17, 2024

Last Update Submit

December 24, 2024

Conditions

Keywords

StenosisTurbulent flowAcoustic signature

Outcome Measures

Primary Outcomes (1)

  • Accuracy

    Diagnostic accuracy of the device (stick-on patch) for indicating the presence or absence of one or more coronary arterial stenoses as indicated by the reference method (angiography/CT angiography results). This will be expressed as: Np/(Na+Np) x100. Where: Np is the number of positive diagnoses of coronary artery disease derived from the patch measurements Na is the number of positive diagnoses of coronary artery disease (with at least one lesion showing a reduction in maximum stenosis lumen diameter 0.8 of more) derived from the angiography images. This is a dimensionless quantity

    Immediately following patch recording and imaging

Secondary Outcomes (3)

  • Stenosis severity

    Immediately following the patch recordings and imaging

  • Patch wearability

    Immediately following the patch recordings and imaging

  • Ease of patch removal

    Immediately following the patch recordings and imaging

Study Arms (2)

Coronary Artery Disease (CAD)

Patients in whom occlusive coronary artery disease has been diagnosed by angiography or CT angiography

Control

Healthy volunteers and/or patients in whom no CAD has been identified on angiography or CT angiography

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Approximately equal numbers of symptomatic and asymptomatic subjects undergoing angiography or CT angiography at the Cleveland Clinic, London, UK

You may qualify if:

  • Patient is able to provide written informed consent
  • Age ≥18 years;
  • Investigation for suspected stable coronary artery disease/stenosis isolated from other cardiac comorbidities.
  • Subjects of either sex. Female subjects of child-bearing potential will be included if deemed suitable for clinically mandated coronary CTa.
  • No infectious disease or neoplasia.

You may not qualify if:

  • Indications to coronary CTa different from isolated suspected stable coronary artery disease, such as acute coronary syndrome, unstable angina, congenital heart disease, cardiomyopathy, heart valve disease, aortic coarctation, electrophysiological disorder/arrhythmia, screening study, unstable clinical condition, left ventricular ejection fraction \<35%, previous coronary revascularization (PCI or CABG surgery), previous heart valve surgery or transcatheter valve replacement, pace maker or implantable defibrillator.
  • If female and of child-bearing potential: evidence of a positive pregnancy test or a stated intention to become pregnant in the next 6-12 months;
  • Currently participating in another device or drug study or has done so in previous 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Portland Place Outpatient Centre 24 Portland Place

London, W1B 1LU, United Kingdom

Location

Related Publications (4)

  • Banks HT, Hu S, Kenz ZR, Kruse C, Shaw S, Whiteman J, Brewin MP, Greenwald SE, Birch MJ. Model validation for a noninvasive arterial stenosis detection problem. Math Biosci Eng. 2014 Jun;11(3):427-48. doi: 10.3934/mbe.2014.11.427.

    PMID: 24506547BACKGROUND
  • Brewin MP, Birch MJ, Mehta DJ, Reeves JW, Shaw S, Kruse C, Whiteman JR, Hu S, Kenz ZR, Banks HT, Greenwald SE. Characterisation of Elastic and Acoustic Properties of an Agar-Based Tissue Mimicking Material. Ann Biomed Eng. 2015 Oct;43(10):2587-96. doi: 10.1007/s10439-015-1294-7. Epub 2015 Mar 14.

    PMID: 25773982BACKGROUND
  • Sangster JF, Oakley CM. Diastolic murmur of coronary artery stenosis. Br Heart J. 1973 Aug;35(8):840-4. doi: 10.1136/hrt.35.8.840. No abstract available.

    PMID: 4542336BACKGROUND
  • Semmlow J, Rahalkar K. Acoustic detection of coronary artery disease. Annu Rev Biomed Eng. 2007;9:449-69. doi: 10.1146/annurev.bioeng.9.060906.151840.

    PMID: 17425468BACKGROUND

MeSH Terms

Conditions

Constriction, Pathologic

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Francesca Pugliese, MD

    Queen Mary University of London

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stephen E Greenwald, PhD

CONTACT

Mark Aichroth

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Cardiovascular Mechanics

Study Record Dates

First Submitted

December 17, 2024

First Posted

December 27, 2024

Study Start

May 1, 2025

Primary Completion

October 1, 2025

Study Completion

December 1, 2025

Last Updated

December 27, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

The results of this preliminary viability study will be described in an internal report and this will be used to provided evidence when seeking funding for a larger validation trial. They will not therefore be published.

Locations